Skip to content
10-Q

Quarterly Report

ACHIEVE LIFE SCIENCES, INC. ACHV

0000950170-25-069806

← back to feed
Filed
May 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 13, 2025 34.69M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $13.02M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $12.75M
Current Liabilities Q1 2025 · Mar 31, 2025 $7.13M
Current Liabilities Q1 2025 · Dec 31, 2024 $6.68M
Total Liabilities Q1 2025 · Mar 31, 2025 $17.08M
Total Liabilities Q1 2025 · Dec 31, 2024 $17.73M
Current Assets Q1 2025 · Mar 31, 2025 $25M
Current Assets Q1 2025 · Dec 31, 2024 $36.47M
Total Assets Q1 2025 · Mar 31, 2025 $27.36M
Total Assets Q1 2025 · Dec 31, 2024 $38.63M
Sga Expense Q1 2025 · Mar 31, 2025 $5.8M
Sga Expense Q1 2025 · Mar 31, 2024 $3.18M
Rd Expense Q1 2025 · Mar 31, 2025 $7.1M
Rd Expense Q1 2025 · Mar 31, 2024 $2.8M
Shares Diluted Q1 2025 · Mar 31, 2024 25.05M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$5.29M
Stockholders Equity Q1 2025 · Mar 31, 2024 $49.46M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$1.45M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.26
Eps Basic Q1 2025 · Mar 31, 2024 −$0.26
Net Income Q1 2025 · Mar 31, 2024 −$6.49M